Title
Category
Credits
Event date
Cost
Optimizing Patient-Reported Outcomes for Enhanced Quality, Experience and Decision-Making in Health Care
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
Patient-reported outcomes (PRO) are crucial in evaluating the impact of health care professionals, teams, and systems on patients’ health, quality of life, and treatment outcomes. By consistently tracking PRO scores, health care organizations can pinpoint areas of excellence and opportunities for improvement, as well as compare the effectiveness of different treatment options. This presentation will explore the benefits of PRO measures in health care and provide insights on how to seamlessly integrate these measures into clinical practice. Strategies for interpreting and utilizing PRO data to improve health care quality will also be highlighted.
CRISPR-Based Therapies for Genetic Blood Disorders
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
Join this session to explore updates in genetic therapy for two prevalent hemaglobinopathies: sickle cell disease and beta thalassemia.
Chronic Kidney Disease: Advancing Strategies to Prevent Progression
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Chronic kidney disease (CKD), typically caused by diabetes and hypertension, affects 15% of US adults and continues to increase with the rising prevalence of these conditions. Increased health care utilization and high morbidity/mortality rates are associated with the progression of CKD to kidney failure with comorbid cardiovascular disease, anemia and bone disease. This session will examine the current state of care for CKD, including recent advancements and interventions that can slow CKD progression and preserve kidney function and strategies to optimize care pathways for managing CKD and its common comorbidities.
Insights into Addressing the Risks of Cardiovascular Health in Women
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity will provide an overview of cardiovascular risk factors specific to women and explore the latest strategies and tools for assessing and mitigating these risks and improving overall cardiovascular care.
New and Emerging Approaches to Diabetes Management
  • Disease management
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 ADA - CERP (Dentists/Allied Dental Staff)
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity will outline the current state of diabetes therapy and review recent data regarding the effectiveness of remission-related approaches. It will also discuss available and emerging AI applications that can assist patients with glycemic control.
The Battle Against Alzheimer’s Disease: New Advancements, Treatments and Hope
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 ADA - CERP (Dentists/Allied Dental Staff)
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Alzheimer’s disease (AD) is a pressing public health crisis, affecting more than 6 million people in the U.S. and increasing in prevalence with the aging population. Join us in exploring the latest advances in AD diagnosis and management, including biomarkers, imaging techniques and cognitive assessments. Emerging pharmacological therapies that target the underlying disease and novel approaches to optimizing patient care will be highlighted.
Racial and Ethnic Inequities in End-of-Life Pain Management
  • Behavioral health
  • Disease management
  • Health equity
  • Palliative care and hospice
  • Wellness
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
Activity description Quality of pain management at the end of life may vary in sociodemographic groups that are often underrepresented. Barriers to care in interracial settings include lack of trust in the health care system, cultural factors including spirituality and the concept of hope, lack of knowledge about services offered, lack of a diverse hospice staff, and access issues.
The Challenging Journey to Diagnosis: A Personal Experience Panel
  • Disease management
  • Rare diseases
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This presentation exams the challenges surrounding rare-disease diagnosis and treatment, delving further into the significant impact of the diagnostic odyssey on adults, children, and their families as they seek care for their rare conditions. A panel of individuals speak about the challenges of their own rare-disease odysseys and provide insight into the pronounced effects their prolonged and necessary diagnostic pursuits have had on their personal lives, finances, and physical and mental health.
What’s Special about Specialty Pharmacy?
  • Disease management
  • 1.00 ACPE - Pharmacists
  • 1.00 ACPE - Pharmacy Technicians
  • 1.00 AMA - Physicians
  • 1.00 ANCC - Nurses
  • 1.00 APA - Psychologists
  • 1.00 Attendance - General Attendance
  • 1.00 CCMC - General - Case Managers
  • 1.00 CDR - Dietitians
  • 1.00 ASWB - Social Workers
$0.00
This session examines the cost of development and growth of these pharmaceuticals and details the specific role that specialty pharmacy plays in making these products accessible. The high costs of therapies and patient and medication management are also discussed along with the role and value of drug benefit programs.
Transition of Care: Our Patients Are Growing Up
  • Disease management
  • Pediatrics
  • 0.75 ACPE - Pharmacists
  • 0.75 ACPE - Pharmacy Technicians
  • 0.75 AMA - Physicians
  • 0.75 ANCC - Nurses
  • 0.75 APA - Psychologists
  • 0.75 Attendance - General Attendance
  • 0.75 CCMC - General - Case Managers
  • 0.75 CDR - Dietitians
  • 0.75 ASWB - Social Workers
$0.00
This activity provides a thorough understanding of the recommended health care transition (HCT) components, considerations and goals that should be constant across HCT planning. It discusses the importance of coordinating the efforts of the health care team, adolescent and family to ensure continuity of care, positive health outcomes, and optimal quality of life.

Pages